• Skip to main content
kleo_logo_final_Bio
  • About
    • Company
  • Pipeline and Programs
    • Pipeline
    • COVID-19 Programs
    • Multiple Myeloma Programs
  • Our Science
    • ARMs
    • ARM NK Combo
    • MATEs
  • News & Events
  • Partnerships

Home

Redefining
Antibody
Therapeutics

Kleo is a targeted immunotherapy company developing synthetic bispecific therapies to emulate or enhance antibodies.

Multiple Myeloma Programs
COVID-19 Programs

Watch the Video to Learn More

Partnering Opportunities

Our technologies enable us to rapidly develop novel immunotherapies against targets of interest with potential partners.

Learn More

Our Lead Programs

Kleo is rapidly advancing multiple candidates in oncology and infectious disease

Learn More

Our Sciences

armsCircle1new
armNKCircle
armsCircleMATEs
No event found!

Print Friendly, PDF & Email

About

  • Company

Our Pipeline

Our Technologies

  • ARMs
  • ARM NK Combo
  • MATEs

Careers

News & Events

Partnerships

© 2019 Kleo Pharmaceuticals. All Rights Reserved.